ETNHX - Eventide Healthcare & Life Sciences Fund CLASS N SHARES

Nasdaq - Nasdaq Delayed Price. Currency in USD
31.92
+0.06 (+0.19%)
At close: 8:00PM EDT
Stock chart is not supported by your current browser
Previous Close31.86
YTD Return19.61%
Expense Ratio (net)1.51%
CategoryHealth
Last Cap Gain0.00
Morningstar Rating★★★★
Morningstar Risk RatingHigh
Sustainability RatingN/A
Net Assets986.15M
Beta (3Y Monthly)1.27
Yield0.00%
5y Average ReturnN/A
Holdings Turnover53.00%
Last Dividend0.00
Average for CategoryN/A
Inception DateDec 27, 2012
  • PR Newswire

    Eventide Gilead Fund and Eventide Healthcare & Life Sciences Fund Named WSJ Category Kings

    BOSTON, April 17, 2019 /PRNewswire/ -- The Eventide Gilead Fund and the Eventide Healthcare & Life Sciences Fund were both named as "Category Kings" by The Wall Street Journal for the one-year period ending March 31, 2019. The Eventide Funds are guided by an approach that seeks to deliver market outperformance to investors by investing in companies whose products and practices help create a better world. Eventide CIO Finny Kuruvilla, MD, PhD, commented on the approach: "Investing, for all its seeming sophistication, is simply the act of owning companies.

  • We're sorry this is all we were able to find about this topic.